Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pomalidomide
Related studies linked through entity extraction aliases.
Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
- Status
- TERMINATED
- Phase
- PHASE1
IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
- Status
- COMPLETED
- Phase
- PHASE2
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
- Status
- COMPLETED
- Phase
- PHASE2